Webb31 dec. 2024 · Philogen S.p.A. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was EUR 23.71 million compared to EUR 2.5 million a year ago. Revenue was EUR 27.3 million compared to EUR 4.96 million a year ago. Net loss was EUR 5.38 million compared to EUR 15.73 million a year ago. Webb11 apr. 2024 · Siena (Italia), 11 aprile 2024 - Philogen S.p.A. ("Philogen" e, insieme alla sua controllata svizzera Philochem AG, il "Gruppo "), con riferimento al programma di acquisto di azioni proprie approvato dal Consiglio di Amministrazione del 24 novembre 2024, in conformità alla delibera dell'Assemblea degli Azionisti tenutasi nella medesima data, …
A phase II study of the L19IL2 immunocytokine in combination …
Webb23 mars 2024 · Philogen SpA entwickelte eine patentierte Technologie, das Iterative Colony Filter Screening, für die Isolierung von monoklonalen Antikörpern, die weder Immunisierung noch Phage Display erfordert. Die Tochtergesellschaften des Unternehmens sind Philotec, Philomed und Philochem. Webb13 feb. 2024 · Philogen is a fully-integrated Swiss-Italian biotechnology company with a mission to innovate the treatment of cancer and other serious conditions. We have the … egypt sadat crossword
Careers - Philogen Spa
Webb11 apr. 2024 · Philogen Spa anunció el martes que había comprado 3.481 de sus propias acciones ordinarias entre el 3 y el 6 de abril. Las acciones se adquirieron a un precio medio de 16,1055 euros por acción, por ... Webb15 Philochem AG, Libernstrasse 3, 8112, Otelfingen, Switzerland. [email protected]. 16 Department of Chemistry and Applied Biosciences, … WebbPhilogen S.p.A., a privately held clinical‐stage biopharmaceutical company, today announced that it has entered into a strategic worldwide license agreement with Pfizer for Dekavil, a novel investigational therapy for autoimmune diseases. Philogen will receive an upfront payment and fold up reusable grocery bags